Hyphens Pharma International Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SGD 162.32 million compared to SGD 125.88 million a year ago. Net income was SGD 11.35 million compared to SGD 6.85 million a year ago.

Basic earnings per share from continuing operations was SGD 0.0368 compared to SGD 0.0227 a year ago. Diluted earnings per share from continuing operations was SGD 0.0366 compared to SGD 0.0227 a year ago.